Top Markets
Coin of the day
Arix Bioscience plc Arix Bioscience plc

Arix Bioscience plc

ARIX
Rang in Aktien #36613
Arix Bioscience plc operates as a venture capital firm, focusing its... Arix Bioscience plc operates as a venture capital firm, focusing its investments across the entire lifecycle of companies, from nascent seed-stage ventures and preclinical or clinical asset development to early, mid, and late-stage growth capital rounds, encompassing both private and public equity. The firm's investment mandate is global, targeting the biotechnology sector and seeking out entities involved in groundbreaking therapeutics, cutting-edge technologies, and broader medical innovations spanning healthcare and life sciences. Employing an evergreen funding model, Arix Bioscience predominantly deploys capital directly from its own balance sheet. It generally prefers to secure a board position within its portfolio companies and strategically exits investments once the peak value has been realized. Established in 2015 and headquartered in London, United Kingdom, the company was previously known as Perceptive Bioscience Investments Limited.
Aktienkurs
$1.93
Zuletzt synchronisiert: 2024-02-09
Marktkapitalisierung
$2.50M
Veränderung (1 Tag)
6.72%
Veränderung (1 Jahr)
0.00%
Land
GB
Handel Arix Bioscience plc (ARIX)

Kategorie

EPS für Arix Bioscience plc (ARIX)
EPS zum 2026 TTM: 0
Laut den aktuellen Finanzberichten und dem Aktienkurs von Arix Bioscience plc beträgt das aktuelle EPS des Unternehmens (TTM) 0. Am Ende des Jahres 2026 betrug das EPS 0 gleich wie dem EPS von 2026, das 0 betrug.
EPS-Verlauf von Arix Bioscience plc von 2026 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
Nicht genügend Daten für die angegebenen Daten.
EPS für ähnliche Unternehmen oder Wettbewerber
Unternehmen EPS EPS-Differenz Land
$17.32 -
US
$27.74 -
NL
- -
CH
- -
KR
$13.70 -
BE